Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V.

J Am Soc Nephrol. 2019 Oct 1. pii: ASN.2019040331. doi: 10.1681/ASN.2019040331. [Epub ahead of print]

PMID:
31575699
2.

Cryptosporidiosis and microsporidiosis as causes of diarrhea in kidney and/or pancreas transplant recipients.

Deltombe C, Lefebvre M, Morio F, Boutoille D, Imbert BM, Le Pape P, Raffi F, Hourmant M.

Med Mal Infect. 2019 Aug 28. pii: S0399-077X(18)30713-3. doi: 10.1016/j.medmal.2019.07.010. [Epub ahead of print]

PMID:
31472993
3.

Immunosuppression and Graft Rejection in Living-Related HLA-Identical Renal Transplantation: The RADOVFULL Study.

Ossman R, Jamme M, Moulin B, Legendre C, Morelon E, Frimat L, Hourmant M, Durrbach A, Malvezzi P, Rostaing L, Taupin JL, Mesnard L, Rondeau E; RADOVFULL Study Group.

Transplantation. 2019 Aug 27. doi: 10.1097/TP.0000000000002937. [Epub ahead of print]

PMID:
31465001
4.

New rules of ABO-compatibility in kidney transplantation.

Hourmant M, Figueres L, Gicquel A, Kimmel C, Garandeau C.

Transfus Clin Biol. 2019 Sep;26(3):180-183. doi: 10.1016/j.tracli.2019.06.002. Epub 2019 Jun 12.

PMID:
31235269
5.

Understanding and managing hypercalciuria in adults with nephrolithiasis: keys for nephrologists.

Figueres L, Hourmant M, Lemoine S.

Nephrol Dial Transplant. 2019 Jun 20. pii: gfz099. doi: 10.1093/ndt/gfz099. [Epub ahead of print] No abstract available.

PMID:
31219589
6.

Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors.

Gaillard F, Courbebaisse M, Kamar N, Rostaing L, Jacquemont L, Hourmant M, Del Bello A, Couzi L, Merville P, Malvezzi P, Janbon B, Moulin B, Maillard N, Dubourg L, Lemoine S, Garrouste C, Pottel H, Legendre C, Delanaye P, Mariat C.

Kidney Int. 2019 Apr;95(4):896-904. doi: 10.1016/j.kint.2018.11.029. Epub 2019 Feb 26.

PMID:
30819555
7.

[What future for renal transplantation facing the challenges of the 2021 transplant program?]

Moulin B, Hourmant M.

Nephrol Ther. 2019 Mar;15(1):1-2. doi: 10.1016/j.nephro.2019.01.002. Epub 2019 Feb 11. French. No abstract available.

PMID:
30765150
8.

Dampening of CD8+ T Cell Response by B Cell Depletion Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Néel A, Bucchia M, Néel M, Tilly G, Caristan A, Yap M, Rimbert M, Bruneau S, Cadoux M, Agard C, Hourmant M, Godmer P, Brouard S, Bressollette C, Hamidou M, Josien R, Fakhouri F, Degauque N.

Arthritis Rheumatol. 2019 Apr;71(4):641-650. doi: 10.1002/art.40766. Epub 2019 Mar 8.

PMID:
30375745
9.

Benefits of kidney transplantation for a national cohort of patients aged 70 years and older starting renal replacement therapy.

Legeai C, Andrianasolo RM, Moranne O, Snanoudj R, Hourmant M, Bauwens M, Soares J, Jacquelinet C, Couchoud C, Macher MA.

Am J Transplant. 2018 Nov;18(11):2695-2707. doi: 10.1111/ajt.15110. Epub 2018 Oct 18.

PMID:
30203618
10.

[Description of immunosuppressive maintenance treatments post kidney transplant through the National System of Health Insurance].

Sitruk L, Couchoud C, Hourmant M, Tuppin P, Macher MA, Legeai C.

Nephrol Ther. 2018 Dec;14(7):523-530. doi: 10.1016/j.nephro.2018.03.004. Epub 2018 Jun 8. French.

PMID:
29887268
11.

Severe Allograft Rejection and Autoimmune Hemolytic Anemia After Anti-PD1 Therapy in a Kidney Transplanted Patient.

Deltombe C, Garandeau C, Renaudin K, Hourmant M.

Transplantation. 2017 Sep;101(9):e291. doi: 10.1097/TP.0000000000001861. No abstract available.

PMID:
29633980
12.

Candida utilis fungaemia following endoscopic intervention on ureteral stent in a kidney transplant recipient: Case report and a review of the literature.

Gaisne R, Jeddi F, Morio F, Le Clerc QC, Hourmant M, Blancho G, Giral M, Cantarovich D, Dantal J, Ville S.

Mycoses. 2018 Aug;61(8):594-599. doi: 10.1111/myc.12766. Epub 2018 Jun 11. Review.

PMID:
29575315
13.

Renal cortical volume: High correlation with pre- and post-operative renal function in living kidney donors.

Gardan E, Jacquemont L, Perret C, Heudes PM, Gourraud PA, Hourmant M, Frampas E, Limou S.

Eur J Radiol. 2018 Feb;99:118-123. doi: 10.1016/j.ejrad.2017.12.013. Epub 2017 Dec 21.

PMID:
29362141
14.

Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome.

Dorval G, Gribouval O, Martinez-Barquero V, Machuca E, Tête MJ, Baudouin V, Benoit S, Chabchoub I, Champion G, Chauveau D, Chehade H, Chouchane C, Cloarec S, Cochat P, Dahan K, Dantal J, Delmas Y, Deschênes G, Dolhem P, Durand D, Ekinci Z, El Karoui K, Fischbach M, Grunfeld JP, Guigonis V, Hachicha M, Hogan J, Hourmant M, Hummel A, Kamar N, Krummel T, Lacombe D, Llanas B, Mesnard L, Mohsin N, Niaudet P, Nivet H, Parvex P, Pietrement C, de Pontual L, Noble CP, Ribes D, Ronco P, Rondeau E, Sallee M, Tsimaratos M, Ulinski T, Salomon R, Antignac C, Boyer O.

Pediatr Nephrol. 2018 Mar;33(3):473-483. doi: 10.1007/s00467-017-3819-9. Epub 2017 Oct 23.

PMID:
29058154
15.

Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study.

Ville S, Imbert-Marcille BM, Coste-Burel M, Garandeau C, Meurette A, Cantarovitch D, Giral M, Hourmant M, Blancho G, Dantal J.

Transpl Int. 2018 May;31(5):484-494. doi: 10.1111/tri.13085. Epub 2018 Jan 16.

16.

PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.

Cornec-Le Gall E, Audrézet MP, Renaudineau E, Hourmant M, Charasse C, Michez E, Frouget T, Vigneau C, Dantal J, Siohan P, Longuet H, Gatault P, Ecotière L, Bridoux F, Mandart L, Hanrotel-Saliou C, Stanescu C, Depraetre P, Gie S, Massad M, Kersalé A, Séret G, Augusto JF, Saliou P, Maestri S, Chen JM, Harris PC, Férec C, Le Meur Y.

Am J Kidney Dis. 2017 Oct;70(4):476-485. doi: 10.1053/j.ajkd.2017.01.046. Epub 2017 Mar 27.

17.

Association between daily haemodialysis, access to renal transplantation and patients' survival in France.

Pladys A, Vigneau C, Hourmant M, Duneau G, Couchoud C, Bayat S; REIN registry.

Nephrology (Carlton). 2018 Mar;23(3):269-278. doi: 10.1111/nep.12974.

18.

Successful treatment of acute promyelocytic leukemia with arsenic trioxide and all-trans retinoic acid in a double lung and kidney transplanted patient.

Peterlin P, Garnier A, Tissot A, Garandeau C, Houreau-Langlard D, Hourmant M, Vantyghem S, Bonnet A, Guillaume T, Béné MC, Le Gouill S, Moreau P, Chevallier P.

Ann Hematol. 2016 Oct;95(10):1737-8. doi: 10.1007/s00277-016-2754-3. Epub 2016 Jul 27. No abstract available.

PMID:
27465153
19.

MICA Mutant A5.1 Influences BK Polyomavirus Reactivation and Associated Nephropathy After Kidney Transplantation.

Tonnerre P, Gérard N, Gavlovsky PJ, Mazalrey S, Hourmant M, Cheneau ML, Cesbron-Gautier A, Renaudin K, Bressollette-Bodin C, Charreau B.

J Infect Dis. 2016 Sep 1;214(5):807-16. doi: 10.1093/infdis/jiw168. Epub 2016 Apr 29.

PMID:
27130430
20.

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.

Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM.

Am J Kidney Dis. 2016 Jul;68(1):84-93. doi: 10.1053/j.ajkd.2015.12.034. Epub 2016 Mar 21.

21.

The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.

Cornec-Le Gall E, Audrézet MP, Rousseau A, Hourmant M, Renaudineau E, Charasse C, Morin MP, Moal MC, Dantal J, Wehbe B, Perrichot R, Frouget T, Vigneau C, Potier J, Jousset P, Guillodo MP, Siohan P, Terki N, Sawadogo T, Legrand D, Menoyo-Calonge V, Benarbia S, Besnier D, Longuet H, Férec C, Le Meur Y.

J Am Soc Nephrol. 2016 Mar;27(3):942-51. doi: 10.1681/ASN.2015010016. Epub 2015 Jul 6.

22.

A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation.

Dusseux E, Albano L, Fafin C, Hourmant M, Guérin O, Couchoud C, Moranne O.

Kidney Int. 2015 Jul;88(1):121-9. doi: 10.1038/ki.2015.25. Epub 2015 Feb 11.

23.

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.

Licht C, Greenbaum LA, Muus P, Babu S, Bedrosian CL, Cohen DJ, Delmas Y, Douglas K, Furman RR, Gaber OA, Goodship T, Herthelius M, Hourmant M, Legendre CM, Remuzzi G, Sheerin N, Trivelli A, Loirat C.

Kidney Int. 2015 May;87(5):1061-73. doi: 10.1038/ki.2014.423. Epub 2015 Feb 4.

24.

Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospital.

Semin-Pelletier B, Cazet L, Bourigault C, Juvin ME, Boutoille D, Raffi F, Hourmant M, Blancho G, Agard C, Connault J, Corvec S, Caillon J, Batard E, Lepelletier D.

J Hosp Infect. 2015 Apr;89(4):248-53. doi: 10.1016/j.jhin.2014.11.018. Epub 2015 Jan 5.

PMID:
25601745
25.

Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.

Figueres ML, Linglart A, Bienaime F, Allain-Launay E, Roussey-Kessler G, Ryckewaert A, Kottler ML, Hourmant M.

Am J Kidney Dis. 2015 Jan;65(1):122-6. doi: 10.1053/j.ajkd.2014.06.037. Epub 2014 Nov 4.

PMID:
25446019
26.

Early and irreversible recurrence MPO-ANCA-positive glomerulonephritis after renal transplantation.

Le Berre L, Dufay A, Cantarovich D, Meurette A, Audrain M, Giral M, Blancho G, Fakhouri F, Hourmant M, Dantal J.

Clin Nephrol. 2015 Jun;83(6):357-62. doi: 10.5414/CN108303.

PMID:
25345380
27.

European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care.

Abramowicz D, Cochat P, Claas FH, Heemann U, Pascual J, Dudley C, Harden P, Hourmant M, Maggiore U, Salvadori M, Spasovski G, Squifflet JP, Steiger J, Torres A, Viklicky O, Zeier M, Vanholder R, Van Biesen W, Nagler E.

Nephrol Dial Transplant. 2015 Nov;30(11):1790-7. doi: 10.1093/ndt/gfu216. Epub 2014 Jul 9.

PMID:
25007790
28.

Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.

Guitard J, Hebral AL, Fakhouri F, Joly D, Daugas E, Rivalan J, Guigonis V, Ducret F, Presne C, Pirson Y, Hourmant M, Glachant JC, Vendrely B, Moranne O, Faguer S, Chauveau D.

Nephrol Dial Transplant. 2014 Nov;29(11):2084-91. doi: 10.1093/ndt/gfu209. Epub 2014 Jun 11.

PMID:
24920841
29.

European renal best practice guideline on the management and evaluation of the kidney donor and recipient.

Pascual J, Abramowicz D, Cochat P, Claas F, Dudley C, Harden P, Heeman U, Hourmant M, Maggiore U, Salvadori M, Spasovski G, Squif JP, Steiger J, Torres A, Vanholder R, Van Biesen W, Viklicky O, Zeier M, Nagler E.

Nefrologia. 2014 May 21;34(3):293-301. doi: 10.3265/Nefrologia.pre2014.Feb.12490. Epub 2014 Mar 10. English, Spanish.

30.

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D'Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V.

N Engl J Med. 2014 Mar 20;370(12):1111-20. doi: 10.1056/NEJMoa1215246.

31.

[20% of living donor kidney transplantation in France? Yes, it's possible!].

Chauvet C, Chauveau P, Hourmant M, Hurault de Ligny B, Kolko A, Lefrançois G, Merville P, Moulin B, Mourad G, Rostaing L, Zins B, Kessler M, Peraldi MN; Commission de transplantation de la Société de néphrologie 2013.

Nephrol Ther. 2013 Dec;9(7):459-60. doi: 10.1016/j.nephro.2013.08.001. Epub 2013 Oct 28. French. No abstract available.

PMID:
24176652
32.

[Access to the waiting list and renal transplantation].

Hourmant M, de Cornelissen F, Brunet P, Pavaday K, Assogba F, Couchoud C, Jacquelinet C; registre du REIN.

Nephrol Ther. 2013 Sep;9 Suppl 1:S139-66. doi: 10.1016/S1769-7255(13)70043-9. French.

PMID:
24119579
33.

Increased soluble Flt-1 correlates with delayed graft function and early loss of peritubular capillaries in the kidney graft.

Chapal M, Néel M, Le Borgne F, Meffray E, Carceles O, Hourmant M, Giral M, Foucher Y, Moreau A, Fakhouri F.

Transplantation. 2013 Oct 27;96(8):739-44. doi: 10.1097/TP.0b013e31829f4772.

PMID:
23912175
34.

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C.

N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981.

35.

Donation from old living donors: how safe is it?

Hourmant M, Lerat L, Karam G.

Nephrol Dial Transplant. 2013 Aug;28(8):2010-4. doi: 10.1093/ndt/gft069. Epub 2013 Mar 29. Review.

PMID:
23543591
36.

Type of PKD1 mutation influences renal outcome in ADPKD.

Cornec-Le Gall E, Audrézet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Férec C, Le Meur Y.

J Am Soc Nephrol. 2013 May;24(6):1006-13. doi: 10.1681/ASN.2012070650. Epub 2013 Feb 21.

37.

[Access to kidney transplantation].

Hourmant M, Kessler M, Beuscart JB, Bauwens M, Brunet P, Jacquelinet C, Couchoud C.

Nephrol Ther. 2012 Sep;8 Suppl 1:S125-47. doi: 10.1016/S1769-7255(12)70031-7. French. No abstract available.

PMID:
23121924
38.

Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.

Zuber J, Le Quintrec M, Krid S, Bertoye C, Gueutin V, Lahoche A, Heyne N, Ardissino G, Chatelet V, Noël LH, Hourmant M, Niaudet P, Frémeaux-Bacchi V, Rondeau E, Legendre C, Loirat C; French Study Group for Atypical HUS.

Am J Transplant. 2012 Dec;12(12):3337-54. doi: 10.1111/j.1600-6143.2012.04252.x. Epub 2012 Sep 7.

39.

[Is it possible to improve access to kidney transplantation waiting list in France?].

Lefrançois G, Chauvet C, Chauveau P, Hourmant M, Hurault de Ligny B, Jacquelinet C, Kolko A, Merville P, Moulin B, Mourad G, Rostaing L, Zins B, Kessler M, Peraldi MN; Commission de transplantation de la Société de néphrologie - 2011.

Nephrol Ther. 2012 Apr;8(2):72-3. doi: 10.1016/j.nephro.2012.01.002. Epub 2012 Feb 28. French. No abstract available.

PMID:
22377694
40.

Kidney and liver transplantation in patients with autosomal recessive polycystic kidney disease: a multicentric study.

Chapal M, Debout A, Dufay A, Salomon R, Roussey G, Burtey S, Launay EA, Vigneau C, Blancho G, Loirat C, Hourmant M, Fakhouri F.

Nephrol Dial Transplant. 2012 May;27(5):2083-8. doi: 10.1093/ndt/gfr588. Epub 2011 Nov 9.

PMID:
22076432
41.

Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis.

Le Roux S, Pepper RJ, Dufay A, Néel M, Meffray E, Lamandé N, Rimbert M, Josien R, Hamidou M, Hourmant M, Cook HT, Charreau B, Larger E, Salama AD, Fakhouri F.

J Am Soc Nephrol. 2012 Jan;23(1):155-64. doi: 10.1681/ASN.2010080858. Epub 2011 Oct 27.

42.

[The evolution of kidney transplantation over the last 20 years].

Hourmant M, Garandeau C.

Presse Med. 2011 Nov;40(11):1074-80. doi: 10.1016/j.lpm.2011.08.003. Epub 2011 Oct 2. French.

PMID:
21964044
43.

Recurrence and graft loss after kidney transplantation for henoch-schonlein purpura nephritis: a multicenter analysis.

Kanaan N, Mourad G, Thervet E, Peeters P, Hourmant M, Vanrenterghem Y, De Meyer M, Mourad M, Maréchal C, Goffin E, Pirson Y.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1768-72. doi: 10.2215/CJN.00520111.

44.

Tuberculosis following kidney transplantation: clinical features and outcome. A French multicentre experience in the last 20 years.

Canet E, Dantal J, Blancho G, Hourmant M, Coupel S.

Nephrol Dial Transplant. 2011 Nov;26(11):3773-8. doi: 10.1093/ndt/gfr156. Epub 2011 Apr 5.

PMID:
21467129
45.

Acute respiratory failure in kidney transplant recipients: a multicenter study.

Canet E, Osman D, Lambert J, Guitton C, Heng AE, Argaud L, Klouche K, Mourad G, Legendre C, Timsit JF, Rondeau E, Hourmant M, Durrbach A, Glotz D, Souweine B, Schlemmer B, Azoulay E.

Crit Care. 2011;15(2):R91. doi: 10.1186/cc10091. Epub 2011 Mar 8.

46.

Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study.

Jacquet A, Pallet N, Kessler M, Hourmant M, Garrigue V, Rostaing L, Kreis H, Legendre C, Mamzer-Bruneel MF.

Transpl Int. 2011 Jun;24(6):582-7. doi: 10.1111/j.1432-2277.2011.01237.x. Epub 2011 Feb 26.

47.

Biomarkers for the diagnosis of the stable kidney transplant and chronic transplant injury using the ProtoArray® technology.

Le Roux S, Devys A, Girard C, Harb J, Hourmant M.

Transplant Proc. 2010 Nov;42(9):3475-81. doi: 10.1016/j.transproceed.2010.09.006.

PMID:
21094800
48.

[Improving long-term graft survival by limiting nephrotoxicity of immunosuppressors and reducing vascular risk].

Hourmant M.

Nephrol Ther. 2009 Dec;5 Suppl 6:S353-4. doi: 10.1016/S1769-7255(09)73424-8. French. No abstract available.

PMID:
20129444
49.

MICA compatibility and immunization in third kidney transplantations.

Gautier AC, Devys A, Cheneau ML, Simon PH, Martin C, Allard S, Hourmant M, Bignon JD.

Transplant Proc. 2009 Mar;41(2):663-5. doi: 10.1016/j.transproceed.2008.12.007.

PMID:
19328950
50.

Bortezomib in the treatment of antibody-mediated rejection--a report of 3 cases.

Mai HL, Cesbron A, Brouard S, Blanchol G, Cantarovich D, Dantal J, Hourmant M, Lino M, Meurette A, Gosselin M, Abbadie O, Soulillou JP, Giral M.

Clin Transpl. 2009:361-8. No abstract available.

PMID:
20524299

Supplemental Content

Loading ...
Support Center